irhythm holdings inc - IRTC

IRTC

Close Chg Chg %
107.35 0.76 0.70%

Closed Market

108.11

+0.76 (0.70%)

Volume: 556.01K

Last Updated:

Jun 5, 2026, 4:00 PM EDT

Company Overview: irhythm holdings inc - IRTC

IRTC Key Data

Open

$109.00

Day Range

106.12 - 109.59

52 Week Range

101.75 - 210.01

Market Cap

$3.53B

Shares Outstanding

32.86M

Public Float

32.27M

Beta

1.27

Rev. Per Employee

N/A

P/E Ratio

N/A

EPS

-$0.86

Yield

0.00%

Dividend

N/A

EX-DIVIDEND DATE

SHORT INTEREST

N/A

AVERAGE VOLUME

547.14K

 

IRTC Performance

1 Week
 
-5.09%
 
1 Month
 
-10.41%
 
3 Months
 
-12.53%
 
1 Year
 
-26.30%
 
5 Years
 
74.11%
 

IRTC Analyst Ratings

  • Sell
  • Under
  • Hold
  • Over
  • Buy
Number of Ratings 15
Full Ratings ➔

About irhythm holdings inc - IRTC

iRhythm Holdings, Inc. is a digital healthcare company, which engages in the provision of design, development, and commercialization of device-based technology to provide ambulatory cardiac monitoring services. It also provides solutions that detect, predict, and prevent disease. The company was founded by Uday N. Kumar in September 2006 and is headquartered in San Francisco, CA.

IRTC At a Glance

iRhythm Holdings, Inc.
699 8th Street
San Francisco, California 94103
Phone 1-415-632-5700 Revenue 747.14M
Industry Medical Specialties Net Income -44,551,000.00
Sector Health Technology 2025 Sales Growth 26.24%
Fiscal Year-end 12 / 2026 Employees 2,400
View SEC Filings

IRTC Valuation

P/E Current N/A
P/E Ratio (with extraordinary items) N/A
P/E Ratio (without extraordinary items) N/A
Price to Sales Ratio 7.601
Price to Book Ratio 37.518
Price to Cash Flow Ratio 70.23
Enterprise Value to EBITDA -563.954
Enterprise Value to Sales 7.798
Total Debt to Enterprise Value 0.125

IRTC Efficiency

Revenue/Employee 311,307.50
Income Per Employee -18,562.917
Receivables Turnover 9.869
Total Asset Turnover 0.766

IRTC Liquidity

Current Ratio 4.627
Quick Ratio 4.484
Cash Ratio 3.843

IRTC Profitability

Gross Margin 70.569
Operating Margin -4.927
Pretax Margin -5.835
Net Margin -5.963
Return on Assets -4.566
Return on Equity -36.569
Return on Total Capital -5.04
Return on Invested Capital -5.306

IRTC Capital Structure

Total Debt to Total Equity 478.693
Total Debt to Total Capital 82.72
Total Debt to Total Assets 71.682
Long-Term Debt to Equity 467.769
Long-Term Debt to Total Capital 80.832
  • Income Statement
  • Balance Sheet
  • Cash Flow Statement

Annual Financials for Irhythm Holdings Inc - IRTC

Collapse All in section
All values USD millions. 2022 2023 2024 2025 5-year trend
Sales/Revenue
410.92M 492.68M 591.84M 747.14M
Sales Growth
+27.29% +19.90% +20.13% +26.24%
Cost of Goods Sold (COGS) incl D&A
129.29M 160.88M 184.31M 219.89M
COGS excluding D&A
- - - -
-
Depreciation & Amortization Expense
19.61M 22.14M 25.78M 26.48M
Depreciation
19.61M 22.14M 25.78M 26.48M
Amortization of Intangibles
- - - -
-
COGS Growth
+18.33% +24.43% +14.57% +19.30%
Gross Income
281.63M 331.81M 407.53M 527.25M
Gross Income Growth
+31.87% +17.82% +22.82% +29.38%
Gross Profit Margin
+68.54% +67.35% +68.86% +70.57%
2022 2023 2024 2025 5-year trend
SG&A Expense
368.81M 445.89M 490.02M 564.06M
Research & Development
46.61M 60.24M 71.46M 84.61M
Other SG&A
322.20M 385.64M 418.56M 479.45M
SGA Growth
+17.64% +20.90% +9.90% +15.11%
Other Operating Expense
- - - -
-
Unusual Expense
26.61M 11.08M 38.70M 14.89M
EBIT after Unusual Expense
(113.78M) (125.16M) (121.19M) (51.70M)
Non Operating Income/Expense
2.04M 6.16M 21.29M 21.25M
Non-Operating Interest Income
- - 21.94M 21.52M
-
Equity in Earnings of Affiliates
- - - -
-
Interest Expense
4.14M 3.65M 12.82M 13.15M
Interest Expense Growth
+253.98% -11.79% +251.26% +2.60%
Gross Interest Expense
4.14M 3.65M 12.82M 13.15M
Interest Capitalized
- - - -
-
Pretax Income
(115.89M) (122.66M) (112.72M) (43.60M)
Pretax Income Growth
-14.75% -5.84% +8.10% +61.32%
Pretax Margin
-28.20% -24.90% -19.05% -5.84%
Income Tax
269.00K 750.00K 565.00K 953.00K
Income Tax - Current - Domestic
160.00K 401.00K 218.00K 622.00K
Income Tax - Current - Foreign
111.00K 349.00K 474.00K 213.00K
Income Tax - Deferred - Domestic
- - - -
-
Income Tax - Deferred - Foreign
- (2.00K) (127.00K) 118.00K
Income Tax Credits
- - - -
-
Equity in Earnings of Affiliates
- - - -
-
Other After Tax Income (Expense)
- - - -
-
Consolidated Net Income
(116.16M) (123.41M) (113.29M) (44.55M)
Minority Interest Expense
- - - -
-
Net Income
(116.16M) (123.41M) (113.29M) (44.55M)
Net Income Growth
-14.60% -6.24% +8.20% +60.67%
Net Margin Growth
-28.27% -25.05% -19.14% -5.96%
Extraordinaries & Discontinued Operations
- - - -
-
Discontinued Operations
- - - -
-
Net Income After Extraordinaries
(116.16M) (123.41M) (113.29M) (44.55M)
Preferred Dividends
- - - -
-
Net Income Available to Common
(116.16M) (123.41M) (113.29M) (44.55M)
EPS (Basic)
-3.8827 -4.0424 -3.6315 -1.392
EPS (Basic) Growth
-12.35% -4.11% +10.16% +61.67%
Basic Shares Outstanding
29.92M 30.53M 31.20M 32.00M
EPS (Diluted)
-3.8827 -4.0424 -3.6315 -1.392
EPS (Diluted) Growth
-12.35% -4.11% +10.16% +61.67%
Diluted Shares Outstanding
29.92M 30.53M 31.20M 32.00M
EBITDA
(67.57M) (91.94M) (56.72M) (10.33M)
EBITDA Growth
+18.93% -36.07% +38.31% +81.78%
EBITDA Margin
-16.44% -18.66% -9.58% -1.38%

Snapshot

Average Recommendation BUY Average Target Price 180.929
Number of Ratings 15 Current Quarters Estimate -0.046
FY Report Date 06 / 2026 Current Year's Estimate -0.008
Last Quarter’s Earnings -0.43 Median PE on CY Estimate N/A
Year Ago Earnings -1.39 Next Fiscal Year Estimate 1.105
Median PE on Next FY Estimate N/A

Earnings Per Share

This Quarter Next Quarter This Fiscal Next Fiscal
# of Estimates 9 9 10 10
Mean Estimate -0.05 0.05 -0.01 1.11
High Estimates 0.09 0.23 0.56 1.84
Low Estimate -0.27 -0.06 -0.56 0.47
Coefficient of Variance -279.20 182.61 -3,896.58 37.45

Analysts Recommendations

Current 1 Month Ago 3 Months Ago
BUY 13 13 13
OVERWEIGHT 1 1 1
HOLD 1 1 1
UNDERWEIGHT 0 0 0
SELL 0 0 0
MEAN Buy Buy Buy

Insider Actions for Irhythm Holdings Inc - IRTC

Date Name Shares Transaction Value
Aug 13, 2025 Abhijit Y. Talwalkar Director 25,611 Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 Non-derivative transaction at $10.71 per share 274,293.81
Aug 13, 2025 Abhijit Y. Talwalkar Director 22,428 Open market or private sale of non-derivative or derivative security Non-derivative transaction at $157.57 per share 3,533,979.96
Aug 13, 2025 Abhijit Y. Talwalkar Director 20,299 Open market or private sale of non-derivative or derivative security Non-derivative transaction at $158.68 per share 3,221,045.32
Aug 13, 2025 Abhijit Y. Talwalkar Director 15,936 Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 0.00
Aug 13, 2025 Donald J. Rosenberg Chief Accounting Officer 10,879 Open market or private sale of non-derivative or derivative security Non-derivative transaction at $158.93 per share 1,728,999.47

Irhythm Holdings Inc in the News